Treatment

Gemcitabina Accord 200 mg concentrado para solución para perfusión clinical trials

1 indexed studies · 0 currently recruiting

AuthorisedPhase I and Phase II (Integrated)- Other
Phase I/II randomized clinical trial of selinexor plus gemcitabine in selected advanced soft-tissue sarcomas
This study is looking into a new treatment for certain advanced soft-tissue sarcomas (a type of cancer). It combines two medicines, selinexor and gemcitabine, to see if it's safe and helps control the cancer for longer.
For: Patients with advanced soft-tissue sarcoma (leiomyosarcoma or malignant peripheral nerve sheath tumor) will receive selinexor in combination with gemcitabine.
Spain